Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials
To access this article, please choose from the options below
PII: S0895-4356(04)00020-4
doi:10.1016/j.jclinepi.2003.12.010
© 2004 Elsevier Inc. All rights reserved.
